I was hoping to get some insight from all of you who have already implemented USP 800. We are closing in on our final details for implementation, but we have one sticking point among the workgroup and the leadership group.

Part of my team wants to keep all drugs on the original NIOSH list and do all required PPE. Part of my team wants to risk-assess and move a lot of "final dosage forms" from Table 2 to the Reproductive Category, as well as decrease required PPE. They are afraid of resource wasting and overkill/"PPE alert fatigue".

Can you humor me and grade the below scenarios for medication errors? We have had an active discussion about what constitutes life saving intervention....

The use of long acting naltrexone is increasing in our community and is under consideration for formulary addition at our facility. How are other facilities dealing with these patients when they come in for emergent surgeries or trauma? We do not have a pain team unfortunately. Any sharing of protocols or procedures would be appreciated.

Thank you
Jeff Ferber, PharmD, MSO

If you are a med safety nurse and planning to attend the American Society of Health-System Pharmacists meeting in Boston for the medication safety program, please consider participating in the "Great safety Debate on Monday afternoon, June 10, 2019.

ASHP has been conducting The Great Safety Debate at their annual Summer Meetings for the past three years, focused on various medication safety topics. This year we hope to have two unique teams each consisting of a medication safety resident/fellow, a nurse, and a pharmacist. The three debate topics this year are:

Hi - wondering if anyone is using color-coded labels for meds placed on the sterile field in the OR or other procedural areas? And, if so, would you mind sharing your color schema (e.g. local anesthetics are x color, contrast is x color). Thank you - Christine

We are setting up naming conventions for Epic, Pyxis, etc... One point of discussion that has come up is putting the dosage form in the name. An example would be metoprolol (LOPRESSOR) 25 mg tablet. It was brought up that we shouldn't include tablet and that it would be assumed it's a tablet otherwise we list capsule, solution, etc... The thought was that, when searching, it would keep medications in a list looking different from each other.

Also do you always include vial or syringe at the end of the medication? We're debating this as well.

Has anyone found certain vials to be too shiny or blurry on camera for IV workflow verification?

Example NDC 16729-267-65: docetaxel has a plastic coating on the vial and we are having troubling viewing the vial in the camera system

Also vincristine is a small vial and it is difficult to see on camera

Does anyone have any tips that they can share to prevent having the pharmacist from gowning and garbing to review a wet check?
TIA

MSOs who have ambulatory care locations, do you have standard 'emergency medications' available in these locations? If yes, can you share your standard list. Our organization is working to standardize the medications stored for this purpose in outpatient locations. Thank you!

Hello,

How is soft (and/or hard) minimum for continuous infusion dosing set in your smart pump library for medications that are titrated to the effect and then weaned off (e.g., vasopressors)?

Thank you in advance.
Viktoriya

One of our pediatric pharmacists has floated the idea of requiring dual pharmacist verification of pediatric orders. We are not a pediatric hospital, but do have a robust NICU, PICU, Peds, and Pediatric ED.

I can't really find any best practices regarding this topic, but I would like to get a feel for other institutions on whether double pharmacist verification is required for Peds patients.

Thank you!